Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles

Gene Therapy

Volumn 3, Issue 4, 1996, Pages 334-342

  Schnierle, B S ^a   Moritz, D ^a,b   Jeschke, M ^a   Groner, B ^a  

^a TUMOR BIOLOGY CENTER   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Envelope protein processing; erbB 2, erbB 3 and erbB 4 receptors; Recombinant retroviral structural proteins; Retroviral docking sites

Indexed keywords

CELL RECEPTOR; ENVELOPE PROTEIN; GAG PROTEIN; MONOCLONAL ANTIBODY; VIRUS RNA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENVELOPE GENE; EXPRESSION VECTOR; GENE FUSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HELPER CELL; MOLECULAR CLONING; MOLONEY MURINE SARCOMA ONCOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR BINDING; STRUCTURAL GENE; TUMOR CELL; VIRUS ASSEMBLY; VIRUS GENE; VIRUS PARTICLE;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; DNA PRIMERS; GENE EXPRESSION; GENE PRODUCTS, ENV; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MOLONEY MURINE LEUKEMIA VIRUS; RECEPTOR, ERBB-2; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; MOLONEY MURINE LEUKEMIA VIRUS; MOLONEY MURINE SARCOMA VIRUS; MURINAE; MURINE SARCOMA ONCOVIRUS; ONCOVIRINAE;

EID: 0029917242     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Gullick WJ. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancer. Br Med Bull 1991; 47: 87-98.
2. Hynes NE. Amplification and overexpression of the ErbB-2 gene in human tumors: its involvement in rumor development, significance as a prognostic factor, and potential as a target for cancer therapy. Semin Cancer Biol 1993; 4: 19-26.
3. Groner B, Hynes NE. Mutations in human breast cancer cells: dominantly acting oncogenes and tumor suppressor genes suggest strategies for targeted interference. Int J Cancer 1990; 5: 40-46.
4. Lemome NR et al. Expression of the ErbB-3 gene product in breast cancer. Br J Cancer 1992; 66: 1116-1121.
5. Plowman GD et al. Ligand-specific activation of HER4/p180 erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 1993; 90: 1746-1750.
6. Weis W et al. Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the ErbB-2 receptor. Cancer Res 1992; 52: 6310-6317.
7. Peles E, Yarden Y. Neu and its ligands: from an oncogene to neural factors. BioEssays 1993; 15: 815-824.
8. Lemmon MA, Schlessinger J. Regulation of signal transduction and signal diversity by receptor oligomerization TIBS 1994; 19. 459-163.
9. Jeschke M et al. Targeted inhibition of tumor cell growth by recombinant heregulin-toxin fusion proteins. Int J Cancer 1995; 60: 730-739.
10. Moritz D, Wels W, Mattern J, Groner B. Cytotoxic T lymphocytes with a grafted recognition specificity for ErbB-2 expressing tumor cells. Proc Natl Acad Sci USA 1994; 91: 4318-4322.
11. Hunter E, Swanstrom D. Retrovirus envelope glycoproteins. Curr Top Microbiol Immunol 1990; 157: 187-253.
12. Morgan R et al. Analysis of the functional and host range-determining regions of the murine ecotropic and amphotropic retrovirus envelope proteins. J Virol 1993; 67: 4712-4721.
13. Battini J-L, Heard J-M, Danos O. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic and polytropic murine leukemia virus. J Virol 1992; 66: 1468-1475.
14. Wels W, Harwerth I-M, Zwickl M, Hardman N, Groner B, Hynes ME. Construction, bacterial expression and characterization of a bifunctional single-chain antibody-phosphate fusion protein targeted to the human erbB-2 receptor. Bio/Technology 1992; 10: 1128-1132.
15. Moritz D, Groner B. A spacer region between the single chain antibody and the CD3 ζ-chain domain of chimeric T cell receptor components is required for efficient ligand binding and signaling activity. Gene Therapy 1994; 2: 539-546.
16. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 1988; 85: 6460-6464.
17. Price J, Turner D, Cepko C. Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci USA 1987; 84: 156-160.
18. Kasahara N, Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor interaction. Science 1994; 266: 1373-1376.
19. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990; 18: 3587-3596.
20. Harwerth I-M et al. Monoclonal antibodies directed to the ErbB-2 receptor inhibit in viva tumour cell growth. Br J Cancer 1993; 68: 1140-1145.
21. Harwerth IM, Wels W, Marte BM, Hynes NE. Monoclonal antibodies against the extracellular domain of the erbB-2 receptor function as partial ligand agonists. J Biol Chem 1992; 267: 15160-15167.
22. Valsesia-Wittmann S et al. Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J Virol 1994; 68: 4609-4619.
23. Tearina Chu T, Martinez I, Sheary WC, Dornburg R. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins. Gene Therapy 1994; 1: 292-299.
24. Russell SJ, Hawkins RE, Winter G. Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res 1993; 21: 1081-1085.
25. Cosset F-L et al. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol 1995; 69: 6314-6322.
26. Etienne-Julan M et al. The efficiency of cell targeting by recombinant retrovirus depends on the nature of the receptor and the composition of the artificial cell-virus linker. J Gen Virol 1992; 73: 3251-3255.
27. Goud B, Legrain P, Buttin G. Antibody-mediated binding of a murine ecotropic moloney retroviral vector to human cells allows internalization but not the establishment of the proviral state. Virology 1988; 163: 251-254.
28. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Press: New York, 1982
29. Harbers K et al. DNA methylation and gene expression: endogenous retroviral genome becomes infectious after molecular cloning. Proc Natl Acad Sci USA 1981; 78: 7609-7613.
30. Shinnick TM, Lerner RA, Sutcliffe GJ. Nucleotide sequence of Moloney murine leukaemia virus. Nature 1981; 293: 543-548.
31. Ausubel FM et al. Current Protocols in Molecular Biology. Green Publishing Associates and Wiley-Interscience, Wiley, New York, USA, 1988.
32. Albritton LM, Kim JW, Tseng L, Cunningham JM. Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses. J Virol 1993; 67: 2091-2096.
33. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.